R. G. D. Natale

The impact of PBRM1 mutations on overall survival in greater than 2,100 patients treated with immune checkpoint blockade (ICB).

R. Motzer, A. Hakimi, I. Ostrovnaya, 2019, Journal of Clinical Oncology.

Interferon signaling promotes tolerance to chromosomal instability during metastatic evolution in renal cancer

Justin K. Huang, S. Signoretti, A. Hakimi, 2023, Nature Cancer.